Vian, 16, has thalassemia and had to have monthly blood transfusions throughout her childhood.

Anthropic’s claim its AI agents discovered an unusual pattern in viral DNA similar to what’s seen in the gene-editing tool CRISPR Cas-9 has set off controversy.

Editas Medicine (EDIT) stock gains as Wells Fargo upgrades after Australia clears the first-in-human trial for the firm's ...

CRISPR is one of this generation’s most profound innovations, with the potential to fundamentally alter the realm of modern ...

Leveraging recently proposed regulatory flexibilities, the gene-editing sector is working to cut R&D costs and unlock ...

The Progeria Research Foundation (PRF) will honor gene-editing pioneer David R. Liu, Ph.D., and longtime supporters Cathy and David Gravel of GraVoc at its 2026 Night of Wonder Gala on Saturday, ...

Oxford researchers have identified the DNA switches that silence the embryonic ζ-globin gene and shown that base editing them ...

Precision BioSciences is transforming drug development for new, potentially first- and best-in-class cell and gene therapies ...

Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...

Scientists have discovered a powerful gene-targeting system in viruses. Billions of years old, VIPR seems to predate CRISPR and may be even more powerful.

Novo Nordisk and Eli Lilly say GLP-1 drugs slowed aging clocks, but the data are early and unreviewed. Here is what patients should know. A study of 1.4 million women links pregnancy complications to ...

Editas Medicine, Inc. ( EDIT) has received regulatory and ethics approval in Australia to begin the first-in-human Phase 1/2 clinical trial of EDIT-401, an experimental gene editing therapy designed ...